✦ LIBER ✦

Ipilimumab and fotemustine in patients with advanced melanoma (NIBIT-M1): an open-label, single-arm phase 2 trial

✍ Scribed by Anna Maria Di Giacomo; Paolo A Ascierto; Lorenzo Pilla; Mario Santinami; Pier Francesco Ferrucci; Diana Giannarelli; Antonella Marasco; Licia Rivoltini; Ester Simeone; Stefania VL Nicoletti; Ester Fonsatti; Diego Annesi; Paola Queirolo; Alessandro Testori; Ruggero Ridolfi; Giorgio Parmiani; Michele Maio

Book ID: 119608962
Publisher: The Lancet
Year: 2012
Tongue: English
Weight: 177 KB
Volume: 13
Category: Article
ISSN: 1470-2045
DOI: 10.1016/s1470-2045(12)70324-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

9305 ORAL A Phase II Study Combining Ipi

9305 ORAL A Phase II Study Combining Ipilimumab and Fotemustine in Patients With Metastatic Melanoma – the NIBIT-M1 Trial

✍ Pi Giacomo, A.M.; Ascierto, P.A.; Pittiglio, E.; Queirolo, P.; Pilla, L.; Ridolf 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Ipilimumab in patients with melanoma and

Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial

✍ Kim Margolin; Marc S Ernstoff; Omid Hamid; Donald Lawrence; David McDermott; Igo 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 129 KB

Tremelimumab for patients with chemother

Tremelimumab for patients with chemotherapy-resistant advanced malignant mesothelioma: an open-label, single-arm, phase 2 trial

✍ Calabrò, Luana; Morra, Aldo; Fonsatti, Ester; Cutaia, Ornella; Amato, Giovanni; 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 431 KB

Pazopanib in advanced and platinum-resis

Pazopanib in advanced and platinum-resistant urothelial cancer: an open-label, single group, phase 2 trial

✍ Andrea Necchi; Luigi Mariani; Nadia Zaffaroni; Lawrence H Schwartz; Patrizia Gia 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 223 KB

An Open-label, Single-arm, Phase 2 Trial

An Open-label, Single-arm, Phase 2 Trial of Panitumumab Plus FOLFIRI as Second-line Therapy in Patients with Metastatic Colorectal Cancer

✍ Allen L. Cohn; Grace C. Shumaker; Pankaj Khandelwal; David A. Smith; Marcus A. N 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 429 KB

Telaprevir for HIV/Hepatitis C Virus-Coi

Telaprevir for HIV/Hepatitis C Virus-Coinfected Patients Failing Treatment With Pegylated Interferon/Ribavirin (ANRS HC26 TelapreVIH): An Open-Label, Single-Arm, Phase 2 Trial

✍ Cotte, L.; Braun, J.; Lascoux-Combe, C.; Vincent, C.; Valantin, M.-A.; Sogni, P. 📂 Article 📅 2014 🏛 University of Chicago Press 🌐 English ⚖ 525 KB